Search

Searching. Please wait…

Mortality predictors and definition proposal for complicated coagulase-negative Staphylococcus bacteraemia: a multicentre prospective cohort study

Abstract: Objectives: the study aimed to explore a definition for complicated coagulase-negative staphylococci bloodstream infections (CoNS BSIs) and to identify predictors for mortality. Methods: a prospective cohort study was conducted from October 2016 to March 2017 in 26 Spanish hospitals. Complicated CoNS BSI criteria included lack of early catheter removal in catheter-related cases, foreign indwelling implant, persistent bacteraemia, fever 72 hours on active therapy, metastatic infection or deep-seated focus, and infective endocarditis. Independent predictors for 30-day mortality were evaluated by Cox regression, and the impact of the definition of complicated bacteraemia was assessed. Results: overall, 445 CoNS BSI cases were included; catheter-related infections were predominant (336/445, 75.5%). Complicated bacteraemia was identified in 240 of 445 patients (53.9%); 30-day mortality in complicated and uncomplicated cases was 53 of 240 (22.1%) and 24/205 (11.7%), respectively (p 0.004). Predictors of 30-day mortality identified in the multivariate analysis included age (hazard ratio [HR]: 1.03, 95% CI: 1.01-1.05), cerebrovascular disease (HR: 2.58, 95% CI: 1.45-4.58), immunosuppressive therapy (HR: 2.16, 95% CI: 1.223.84), SOFA score (HR: 1.09, 95% CI: 1.031.16), and complicated bacteraemia (HR: 2.14, 95% CI: 1.293.53). A catheter-related source of bacteraemia was found to be protective (HR: 0.49, 95% CI: 0.300.80). When specific criteria to define complicated bacteraemia were included, fever 72 hours was associated with an increased risk of death (HR: 2.52, 95% CI: 1.52-4.17) and early catheter removal was protective (HR: 0.47, 95% CI: 0.260.83). Discussion: a high proportion of patients presented complicated bacteraemia according to the proposed criteria; these patients had higher hazards for mortality. Other mortality predictors were identified. Further studies would be needed to validate the proposed criteria.

 Fuente: Clinical Microbiology and Infection, 2024, S1198-743X(24)00603-7

 Publisher: Elsevier

 Year of publication: 2024

 Publication type: Artículo de Revista

 DOI: 10.1016/j.cmi.2024.12.016

 ISSN: 1198-743X,1469-0691

 Publication Url: https://doi.org/10.1016/j.cmi.2024.12.016

Authorship

VARISCO, BENEDETTA

MARTÍNEZ PÉRE CRESPO, PEDRO MARÍA

RETAMAR GENTIL, PILAR

HERNANDEZ, INMACULADA LÓPEZ

FERNÁNDEZ NATAL, ISABEL

PÉREZ RODRÍGUEZ, MARÍA TERESA

GOIKOETXEA AGUIRRE, ANE JOSUNE

SÁNCHEZ CALVO, JUAN MANUEL

MARTÍN, LUIS BUZÓN

LEÓN JIMÉNEZ, EVA

GARCÍA, DAVID VINUESA

REGUERA IGLESIAS, JOSÉ MARÍA

BAHAMONDE CARRASCO, ALBERTO

SUÁREZ, JONATHAN FERNÁNDEZ

RODRÍGUEZ BAÑO, JESÚS

LÓPEZ CORTÉS, LUIS EDUARDO